Drug profile · INN
ritlecitinib tosilate
LITFULO
ritlecitinib tosilate (LITFULO) is a tec family kinase inhibitor.
PMDA: approved
Patents linked 0
Pipeline programs 8
News articles 0
Drug details — ritlecitinib tosilate
- Class
- —
- Route
- —
- Patents
- 0
- Programs
- 8
- Data quality
- 0.78
Quick answer
ritlecitinib tosilate (LITFULO) is a tec family kinase inhibitor.
Key facts
INN ritlecitinib tosilate
Brand LITFULO
Mechanism TEC family kinase inhibitor
Target TEC family kinase
Mechanism of action
TEC family kinase inhibitor
Primary target: TEC family kinase
Approval history
| Authority | Status | Date |
|---|---|---|
| PMDA | approved | — |
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is ritlecitinib tosilate?
ritlecitinib tosilate (LITFULO) is a tec family kinase inhibitor.
What is the brand name for ritlecitinib tosilate?
LITFULO is a marketed brand name for ritlecitinib tosilate. Check FDA Drugs@FDA for the current US label holder and prescribing information.